Millennium Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-846,008
Closed -$3.37M – 6014
2025
Q4
$3.37M Buy
846,008
+823,555
+3,668% +$3.64M ﹤0.01% 3430
2025
Q3
$84.9K Buy
+22,453
New +$76.2K ﹤0.01% 5741
2025
Q2
– Sell
-61,478
Closed -$50.7K – 6086
2025
Q1
$50.7K Sell
61,478
-36,271
-37% -$34.4K ﹤0.01% 5536
2024
Q4
$83.1K Buy
97,749
+86,424
+763% +$96.2K ﹤0.01% 5509
2024
Q3
$14K Sell
11,325
-28,983
-72% -$36.3K ﹤0.01% 5834
2024
Q2
$67.3K Sell
40,308
-53,200
-57% -$95.1K ﹤0.01% 5375
2024
Q1
$174K Sell
93,508
-97,793
-51% -$180K ﹤0.01% 5420
2023
Q4
$363K Sell
191,301
-363,445
-66% -$543K ﹤0.01% 4842
2023
Q3
$732K Buy
+554,746
New +$1.22M ﹤0.01% 4404
2023
Q2
– Sell
-690,767
Closed -$2.39M – 6375
2023
Q1
$2.39M Buy
690,767
+308,125
+81% +$1.49M ﹤0.01% 3265
2022
Q4
$1.6M Buy
382,642
+338,675
+770% +$1.28M ﹤0.01% 3753
2022
Q3
$176K Buy
43,967
+13,080
+42% +$99.2K ﹤0.01% 5731
2022
Q2
$349K Sell
30,887
-150,466
-83% -$1.8M ﹤0.01% 5240
2022
Q1
$2.94M Buy
181,353
+112,374
+163% +$2.88M ﹤0.01% 3517
2021
Q4
$3.27M Buy
68,979
+10,450
+18% +$627K ﹤0.01% 3307
2021
Q3
$4.24M Buy
58,529
+32,669
+126% +$2.36M ﹤0.01% 3055
2021
Q2
$2.17M Sell
25,860
-304,036
-92% -$20.1M ﹤0.01% 3862
2021
Q1
$16M Buy
329,896
+299,397
+982% +$16.2M 0.01% 1296
2020
Q4
$1.44M Buy
30,499
+26,123
+597% +$1.03M ﹤0.01% 3478
2020
Q3
$206K Buy
+4,376
New +$144K ﹤0.01% 4046
2020
Q2
– Sell
-17,193
Closed -$224K – 4362
2020
Q1
$224K Buy
+17,193
New +$215K ﹤0.01% 3328

Other funds holding NBP

Millennium Management's NBP Position: Q1 2026 in Review

Millennium Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 846,008 shares — an estimated $3.37M sold.

Millennium Management first reported a position in NBP in Q1 2020 and held it in 21 quarters. The position peaked at $16M in Q1 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Millennium Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 846,008 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $3.37M.
  • Millennium Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 21 quarters.
  • Millennium Management's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.